Cysteamine Therapy

Cysteamine Therapy is a topical depigmenting treatment modality that utilizes cysteamine, a low-molecular-weight aminothiol, to inhibit melanin synthesis through its antioxidant properties and direct interference with tyrosinase activity, thereby reducing hyperpigmentation.

348

Publications

14.7K

Citations

1.6K

Authors

559

Institutions

Publications per year

2017–2026

69

Authors

1.6K

  1. EL
    Elena Levtchenko

    KU Leuven, Belgium

    18 publications · 759 citations

    16

    h-index

  2. WA
    William A. Gahl

    National Human Genome Research Institute, United States

    17 publications · 1.6K citations

    15

    h-index

  3. JA
    Jerry A. Schneider

    University of California San Diego, United States

    13 publications · 1.1K citations

    13

    h-index

  4. JG
    Jess G. Thoene

    University of Michigan, United States

    10 publications · 1.1K citations

    10

    h-index

  5. LP
    Lambertus P. van den Heuvel

    Radboud University Nijmegen, Netherlands

    9 publications · 378 citations

    9

    h-index

1–5 of 1.6K

Venues

  1. PubMed

    Repository · 19 publications · 616 citations

    13

    h-index

  2. Endocrinology

    10 publications · 361 citations

    10

    h-index

  3. The Journal of Pediatrics

    9 publications · 361 citations

    9

    h-index

  4. Brain Research

    8 publications · 467 citations

    8

    h-index

  5. PLoS ONE

    7 publications · 232 citations

    7

    h-index

1–5